ID   5HT3B_HUMAN             Reviewed;         441 AA.
AC   O95264; B0YJ23; Q0VJC3;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   28-JUN-2023, entry version 173.
DE   RecName: Full=5-hydroxytryptamine receptor 3B;
DE            Short=5-HT3-B;
DE            Short=5-HT3B;
DE   AltName: Full=Serotonin receptor 3B;
DE   Flags: Precursor;
GN   Name=HTR3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Small intestine;
RX   PubMed=10521471; DOI=10.1074/jbc.274.43.30799;
RA   Dubin A.E., Huvar R., D'Andrea M.R., Pyati J., Zhu J.Y., Joy K.C.,
RA   Wilson S.J., Galindo J.E., Glass C.A., Luo L., Jackson M.R.,
RA   Lovenberg T.W., Erlander M.G.;
RT   "The pharmacological and functional characteristics of the serotonin 5-
RT   HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit.";
RL   J. Biol. Chem. 274:30799-30810(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND SUBUNIT.
RX   PubMed=9950429; DOI=10.1038/16941;
RA   Davies P.A., Pistis M., Hanna M.C., Peters J.A., Lambert J.J., Hales T.G.,
RA   Kirkness E.F.;
RT   "The 5-HT3B subunit is a major determinant of serotonin-receptor
RT   function.";
RL   Nature 397:359-363(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT SER-129.
RC   TISSUE=Brain;
RX   PubMed=17010535; DOI=10.1016/j.gene.2006.08.002;
RA   Tzvetkov M.V., Meineke C., Oetjen E., Hirsch-Ernst K., Brockmoller J.;
RT   "Tissue-specific alternative promoters of the serotonin receptor gene HTR3B
RT   in human brain and intestine.";
RL   Gene 386:52-62(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   FUNCTION, AND REGION.
RX   PubMed=12867984; DOI=10.1038/nature01788;
RA   Kelley S.P., Dunlop J.I., Kirkness E.F., Lambert J.J., Peters J.A.;
RT   "A cytoplasmic region determines single-channel conductance in 5-HT3
RT   receptors.";
RL   Nature 424:321-324(2003).
RN   [7]
RP   SUBUNIT.
RX   PubMed=17392525; DOI=10.1124/mol.106.032144;
RA   Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J., Rietdorf J.,
RA   Boenisch H., Goethert M., Rappold G., Bruess M.;
RT   "Characterization of the novel human serotonin receptor subunits 5-HT3C, 5-
RT   HT3D, and 5-HT3E.";
RL   Mol. Pharmacol. 72:8-17(2007).
RN   [8]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-52; ASN-96; ASN-138; ASN-168 AND
RP   ASN-203, AND MUTAGENESIS OF ASN-52; ASN-96; ASN-138; ASN-168 AND ASN-203.
RX   PubMed=21138434; DOI=10.1111/j.1471-4159.2010.07129.x;
RA   Massoura A.N., Dover T.J., Newman A.S., Barnes N.M.;
RT   "The identification of N-glycosylated residues of the human 5-HT3B receptor
RT   subunit: importance for cell membrane expression.";
RL   J. Neurochem. 116:975-983(2011).
RN   [9]
RP   VARIANTS SER-129; ARG-156 AND ILE-183.
RX   PubMed=15389765; DOI=10.1002/ajmg.b.30070;
RA   Frank B., Niesler B., Noethen M.M., Neidt H., Propping P., Bondy B.,
RA   Rietschel M., Maier W., Albus M., Rappold G.;
RT   "Investigation of the human serotonin receptor gene HTR3B in bipolar
RT   affective and schizophrenic patients.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 131:1-5(2004).
RN   [10]
RP   VARIANTS SER-129; ARG-156 AND ILE-183.
RX   PubMed=15293096; DOI=10.1007/s10067-004-0927-2;
RA   Frank B., Niesler B., Bondy B., Spaeth M., Pongratz D.E., Ackenheil M.,
RA   Fischer C., Rappold G.;
RT   "Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in
RT   fibromyalgia patients.";
RL   Clin. Rheumatol. 23:338-344(2004).
RN   [11]
RP   VARIANTS SER-129; THR-143 AND ILE-183.
RX   PubMed=16487942; DOI=10.1016/j.biopsych.2005.11.008;
RA   Yamada K., Hattori E., Iwayama Y., Ohnishi T., Ohba H., Toyota T.,
RA   Takao H., Minabe Y., Nakatani N., Higuchi T., Detera-Wadleigh S.D.,
RA   Yoshikawa T.;
RT   "Distinguishable haplotype blocks in the HTR3A and HTR3B region in the
RT   Japanese reveal evidence of association of HTR3B with female major
RT   depression.";
RL   Biol. Psychiatry 60:192-201(2006).
RN   [12]
RP   VARIANT ARG-156.
RX   PubMed=21179162; DOI=10.1038/nature09629;
RA   Bevilacqua L., Doly S., Kaprio J., Yuan Q., Tikkanen R., Paunio T.,
RA   Zhou Z., Wedenoja J., Maroteaux L., Diaz S., Belmer A., Hodgkinson C.A.,
RA   Dell'osso L., Suvisaari J., Coccaro E., Rose R.J., Peltonen L.,
RA   Virkkunen M., Goldman D.;
RT   "A population-specific HTR2B stop codon predisposes to severe
RT   impulsivity.";
RL   Nature 468:1061-1066(2010).
CC   -!- FUNCTION: This is one of the several different receptors for 5-
CC       hydroxytryptamine (serotonin), a biogenic hormone that functions as a
CC       neurotransmitter, a hormone, and a mitogen. This receptor is a ligand-
CC       gated ion channel, which when activated causes fast, depolarizing
CC       responses. It is a cation-specific, but otherwise relatively
CC       nonselective, ion channel. {ECO:0000269|PubMed:12867984}.
CC   -!- SUBUNIT: Forms a pentaheteromeric complex with HTR3A. Not functional as
CC       a homomeric complex. {ECO:0000269|PubMed:17392525,
CC       ECO:0000269|PubMed:9950429}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21138434};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:21138434}.
CC       Note=Presumably retained within the endoplasmic reticulum unless
CC       complexed with HTR3A.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95264-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95264-2; Sequence=VSP_029796;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain cortex, in the caudate
CC       nucleus, the hippocampus, the thalamus and the amygdala. Detected in
CC       the kidney and testis as well as in monocytes of the spleen, small and
CC       large intestine, uterus, prostate, ovary and placenta.
CC       {ECO:0000269|PubMed:10521471, ECO:0000269|PubMed:9950429}.
CC   -!- PTM: N-glycosylation required for membrane localization.
CC       {ECO:0000269|PubMed:21138434}.
CC   -!- MISCELLANEOUS: The HA-stretch region of HTR3B seems to confer increased
CC       conductance to HTR3A/HTR3B heteromers compared to that of HTR3A
CC       homomers.
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3B sub-
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF169255; AAF03691.1; -; mRNA.
DR   EMBL; AF080582; AAD12242.1; -; mRNA.
DR   EMBL; AM293589; CAL25321.1; -; mRNA.
DR   EMBL; EF444985; ACA06001.1; -; Genomic_DNA.
DR   EMBL; AK314268; BAG36930.1; -; mRNA.
DR   CCDS; CCDS8364.1; -. [O95264-1]
DR   CCDS; CCDS86249.1; -. [O95264-2]
DR   RefSeq; NP_006019.1; NM_006028.4. [O95264-1]
DR   RefSeq; XP_011541365.1; XM_011543063.1.
DR   AlphaFoldDB; O95264; -.
DR   SMR; O95264; -.
DR   BioGRID; 114615; 54.
DR   ComplexPortal; CPX-271; 5-hydroxytryptamine-3A/B receptor complex.
DR   IntAct; O95264; 1.
DR   STRING; 9606.ENSP00000260191; -.
DR   BindingDB; O95264; -.
DR   ChEMBL; CHEMBL3895; -.
DR   DrugBank; DB01239; Chlorprothixene.
DR   DrugBank; DB11273; Dihydroergocornine.
DR   DrugBank; DB13345; Dihydroergocristine.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB01049; Ergoloid mesylate.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB12141; Gilteritinib.
DR   DrugBank; DB00715; Paroxetine.
DR   DrugBank; DB08839; Serotonin.
DR   DrugBank; DB09304; Setiptiline.
DR   DrugBank; DB13025; Tiapride.
DR   DrugBank; DB00246; Ziprasidone.
DR   DrugCentral; O95264; -.
DR   GuidetoPHARMACOLOGY; 374; -.
DR   TCDB; 1.A.9.2.5; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family.
DR   GlyCosmos; O95264; 6 sites, No reported glycans.
DR   GlyGen; O95264; 6 sites.
DR   iPTMnet; O95264; -.
DR   PhosphoSitePlus; O95264; -.
DR   BioMuta; HTR3B; -.
DR   MassIVE; O95264; -.
DR   PaxDb; O95264; -.
DR   PeptideAtlas; O95264; -.
DR   TopDownProteomics; O95264-1; -. [O95264-1]
DR   Antibodypedia; 18362; 202 antibodies from 30 providers.
DR   DNASU; 9177; -.
DR   Ensembl; ENST00000260191.8; ENSP00000260191.2; ENSG00000149305.8. [O95264-1]
DR   Ensembl; ENST00000537778.5; ENSP00000443118.1; ENSG00000149305.8. [O95264-2]
DR   GeneID; 9177; -.
DR   KEGG; hsa:9177; -.
DR   MANE-Select; ENST00000260191.8; ENSP00000260191.2; NM_006028.5; NP_006019.1.
DR   UCSC; uc001pok.4; human. [O95264-1]
DR   AGR; HGNC:5298; -.
DR   CTD; 9177; -.
DR   DisGeNET; 9177; -.
DR   GeneCards; HTR3B; -.
DR   HGNC; HGNC:5298; HTR3B.
DR   HPA; ENSG00000149305; Tissue enriched (brain).
DR   MIM; 604654; gene.
DR   neXtProt; NX_O95264; -.
DR   OpenTargets; ENSG00000149305; -.
DR   PharmGKB; PA29556; -.
DR   VEuPathDB; HostDB:ENSG00000149305; -.
DR   eggNOG; KOG3645; Eukaryota.
DR   GeneTree; ENSGT00940000158478; -.
DR   HOGENOM; CLU_018074_5_0_1; -.
DR   InParanoid; O95264; -.
DR   OMA; NMANEVP; -.
DR   OrthoDB; 5489962at2759; -.
DR   PhylomeDB; O95264; -.
DR   TreeFam; TF315605; -.
DR   PathwayCommons; O95264; -.
DR   Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission.
DR   SignaLink; O95264; -.
DR   SIGNOR; O95264; -.
DR   BioGRID-ORCS; 9177; 14 hits in 1151 CRISPR screens.
DR   GeneWiki; HTR3B; -.
DR   GenomeRNAi; 9177; -.
DR   Pharos; O95264; Tchem.
DR   PRO; PR:O95264; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; O95264; protein.
DR   Bgee; ENSG00000149305; Expressed in prefrontal cortex and 45 other tissues.
DR   ExpressionAtlas; O95264; baseline and differential.
DR   Genevisible; O95264; HS.
DR   GO; GO:0009986; C:cell surface; IDA:CACAO.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:InterPro.
DR   GO; GO:1904602; C:serotonin-activated cation-selective channel complex; IGI:GO_Central.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:0030594; F:neurotransmitter receptor activity; IBA:GO_Central.
DR   GO; GO:0022850; F:serotonin-gated monoatomic cation-selective channel activity; IGI:GO_Central.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0098662; P:inorganic cation transmembrane transport; IDA:ComplexPortal.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0050877; P:nervous system process; IBA:GO_Central.
DR   GO; GO:0042391; P:regulation of membrane potential; IBA:GO_Central.
DR   GO; GO:0007210; P:serotonin receptor signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd19012; LGIC_ECD_5-HT3B; 1.
DR   CDD; cd19063; LGIC_TM_5-HT3; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 1.
DR   InterPro; IPR008132; 5HT3_rcpt.
DR   InterPro; IPR008134; 5HT3_rcpt_B.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   PANTHER; PTHR18945:SF53; 5-HYDROXYTRYPTAMINE RECEPTOR 3B; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR01710; 5HT3BRECEPTR.
DR   PRINTS; PR01708; 5HT3RECEPTOR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   TIGRFAMs; TIGR00860; LIC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Membrane; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..441
FT                   /note="5-hydroxytryptamine receptor 3B"
FT                   /id="PRO_0000312289"
FT   TOPO_DOM        22..238
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        239..259
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        260..268
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        269..286
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        287..303
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        304..324
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        325..414
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        415..435
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        436..441
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REGION          381..413
FT                   /note="HA-stretch"
FT   CARBOHYD        52
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21138434"
FT   CARBOHYD        96
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21138434"
FT   CARBOHYD        138
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21138434"
FT   CARBOHYD        168
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21138434"
FT   CARBOHYD        203
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21138434"
FT   CARBOHYD        287
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        155..169
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..17
FT                   /note="MLSSVMAPLWACILVAA -> MIVYFP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17010535"
FT                   /id="VSP_029796"
FT   VARIANT         129
FT                   /note="Y -> S (in dbSNP:rs1176744)"
FT                   /evidence="ECO:0000269|PubMed:15293096,
FT                   ECO:0000269|PubMed:15389765, ECO:0000269|PubMed:16487942,
FT                   ECO:0000269|PubMed:17010535"
FT                   /id="VAR_037472"
FT   VARIANT         143
FT                   /note="I -> T (in dbSNP:rs34550504)"
FT                   /evidence="ECO:0000269|PubMed:16487942"
FT                   /id="VAR_037473"
FT   VARIANT         156
FT                   /note="S -> R (in dbSNP:rs72466469)"
FT                   /evidence="ECO:0000269|PubMed:15293096,
FT                   ECO:0000269|PubMed:15389765, ECO:0000269|PubMed:21179162"
FT                   /id="VAR_037474"
FT   VARIANT         183
FT                   /note="V -> I (in dbSNP:rs17116138)"
FT                   /evidence="ECO:0000269|PubMed:15293096,
FT                   ECO:0000269|PubMed:15389765, ECO:0000269|PubMed:16487942"
FT                   /id="VAR_037475"
FT   MUTAGEN         52
FT                   /note="N->S: Reduced molecular weight. Very little
FT                   expression in the cell membrane."
FT                   /evidence="ECO:0000269|PubMed:21138434"
FT   MUTAGEN         96
FT                   /note="N->S: Reduced molecular weight. Very little
FT                   expression in the cell membrane."
FT                   /evidence="ECO:0000269|PubMed:21138434"
FT   MUTAGEN         138
FT                   /note="N->S: Reduced molecular weight. Very little
FT                   expression in the cell membrane."
FT                   /evidence="ECO:0000269|PubMed:21138434"
FT   MUTAGEN         168
FT                   /note="N->S: Reduced molecular weight and cell membrane
FT                   expression."
FT                   /evidence="ECO:0000269|PubMed:21138434"
FT   MUTAGEN         203
FT                   /note="N->S: Reduced molecular weight. Very little
FT                   expression in the cell membrane."
FT                   /evidence="ECO:0000269|PubMed:21138434"
SQ   SEQUENCE   441 AA;  50292 MW;  2ED59E4E11400648 CRC64;
     MLSSVMAPLW ACILVAAGIL ATDTHHPQDS ALYHLSKQLL QKYHKEVRPV YNWTKATTVY
     LDLFVHAILD VDAENQILKT SVWYQEVWND EFLSWNSSMF DEIREISLPL SAIWAPDIII
     NEFVDIERYP DLPYVYVNSS GTIENYKPIQ VVSACSLETY AFPFDVQNCS LTFKSILHTV
     EDVDLAFLRS PEDIQHDKKA FLNDSEWELL SVSSTYSILQ SSAGGFAQIQ FNVVMRRHPL
     VYVVSLLIPS IFLMLVDLGS FYLPPNCRAR IVFKTSVLVG YTVFRVNMSN QVPRSVGSTP
     LIGHFFTICM AFLVLSLAKS IVLVKFLHDE QRGGQEQPFL CLRGDTDADR PRVEPRAQRA
     VVTESSLYGE HLAQPGTLKE VWSQLQSISN YLQTQDQTDQ QEAEWLVLLS RFDRLLFQSY
     LFMLGIYTIT LCSLWALWGG V
//
